Tests ID'd for use in outcome assessment of spinal stenosis

July 12, 2012
Tests ID'd for use in outcome assessment of spinal stenosis
For patients with lumbar spinal stenosis the Oswestry Disability Index, Modified Swiss Spinal Stenosis Scale, and Patient Specific Functional Scale have been shown to possess adequate psychometric properties for use in assessment of outcome, according to a study published online July 2 in The Spine Journal.

(HealthDay) -- For patients with lumbar spinal stenosis the Oswestry Disability Index, Modified Swiss Spinal Stenosis Scale (SSS), and Patient Specific Functional Scale have been shown to possess adequate psychometric properties for use in assessment of outcome, according to a study published online July 2 in The Spine Journal.

Joshua A. Cleland, P.T., Ph.D., from Franklin Pierce University in Concord, N.H., and colleagues conducted a secondary analysis of 55 patients (mean age, 69.5 years; 43.1 percent female) with lumbar receiving outpatient participating in a . The Oswestry Disability Index, SSS, Patient Specific Functional Scale, and Numeric Pain Rating Scale (NPRS) were completed at baseline and follow-up in order to assess test-retest reliability, , and minimum levels of detectable and clinically important differences. To categorize whether patients experienced clinically meaningful change, a 15-point Global Rating of Change was conducted at follow-up.

The researchers found that the only outcome measure which showed excellent test-retest reliability was the Oswestry Disability Index, with an intraclass correlation coefficient of 0.86; all other measures ranged between fair and moderate. The Oswestry Disability Index, SSS, and Patient Specific Functional Scale showed varying levels of responsiveness but were superior to the NPRS. For the Oswestry Disability Index the minimal clinically important difference was five points.

"The results of our study indicate that the Oswestry Disability Index, SSS, and Patient Specific Functional Scale possess adequate psychometric properties to be used in the outcome assessment of patients with lumbar spinal stenosis," the authors conclude.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Classification-based therapy no better for back pain

February 21, 2012

(HealthDay) -- Treatment of patients with lower back pain (LBP) using a classification-based physical therapy approach shows no statistically significant superiority to treatment with usual physical therapy care, according ...

Lumbar spinal stenosis lowers health-related QoL

April 7, 2012

(HealthDay) -- Patients diagnosed with lumbar spinal stenosis (LSS) have a substantial burden of illness and reduced health-related quality of life (HRQL) compared to the general population, and their HRQL is compounded by ...

Prolonged disability predictors identified for low back pain

June 28, 2012

(HealthDay) -- In patients with chronic nonspecific low back pain (LBP), impaired fasting glucose tolerance, greater pain-related disability, higher body mass index, and lower quality of life (QoL) at baseline are all associated ...

Recommended for you

Experimental MERS vaccine shows promise in animal studies

July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...

Can social isolation fuel epidemics?

July 21, 2015

Conventional wisdom has it that the more people stay within their own social groups and avoid others, the less likely it is small disease outbreaks turn into full-blown epidemics. But the conventional wisdom is wrong, according ...

Lack of knowledge on animal disease leaves humans at risk

July 20, 2015

Researchers from the University of Sydney have painted the most detailed picture to date of major infectious diseases shared between wildlife and livestock, and found a huge gap in knowledge about diseases which could spread ...

IBD genetically similar in Europeans and non-Europeans

July 20, 2015

The first genetic study of inflammatory bowel disease (IBD) to include individuals from diverse populations has shown that the regions of the genome underlying the disease are consistent around the world. This study, conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.